Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jordana Cohen and Andrew South.
Jordana Cohen
Connection Strength
2.616
Andrew South
  1. Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding. J Hypertens. 2021 04 01; 39(4):795-805.
    View in: PubMed
    Score: 0.938
  2. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System. Curr Hypertens Rep. 2020 06 26; 22(7):44.
    View in: PubMed
    Score: 0.889
  3. Renin-angiotensin system blockade in the COVID-19 pandemic. Clin Kidney J. 2021 Mar; 14(Suppl 1):i48-i59.
    View in: PubMed
    Score: 0.232
  4. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System. Adv Chronic Kidney Dis. 2020 09; 27(5):404-411.
    View in: PubMed
    Score: 0.223
  5. Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19". Circ Res. 2020 06 05; 126(12):e140-e141.
    View in: PubMed
    Score: 0.221
  6. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One. 2021; 16(4):e0248080.
    View in: PubMed
    Score: 0.059
  7. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19. Clin J Am Soc Nephrol. 2020 May 07; 15(5):714-716.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.